Select BCL-2 Antagonism Restores Chemotherapy Sensitivity in High-Risk Neuroblastoma
BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2129-0
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2016
Authors
Publisher
Springer Science and Business Media LLC